Spencer E. Brightman
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Microbiology top 10%
- Bacterial Infections and Vaccines
Papers in
- Immunology 12
- Immunotherapy and Immune Responses 8
- Immune Response and Inflammation 5
- Atherosclerosis and Cardiovascular Diseases 1
- Oncology 7
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Bruce R. Zetter (1 shared paper)Stephen P. Schoenberger (6 shared papers)Ofer Levy (7 shared papers)David J. Dowling (7 shared papers)Aaron M. Miller (4 shared papers)Martin S. Naradikian (5 shared papers)Carlo Pietrasanta (3 shared papers)Ilana Bergelson (3 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Current Opinion in Cell Biology (1 paper)Science Translational Medicine (1 paper)Scientific Reports (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
Spencer E. Brightman
14 papers receiving 380 citations
Peers
Comparison fields: 5 of 67
- Immunology 240
- Microbiology 36
- Oncology 94
- Immunology and Allergy 17
- Infectious Diseases 51
Countries citing papers authored by Spencer E. Brightman
This map shows the geographic impact of Spencer E. Brightman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer E. Brightman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer E. Brightman more than expected).
Fields of papers citing papers by Spencer E. Brightman
This network shows the impact of papers produced by Spencer E. Brightman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer E. Brightman. The network helps show where Spencer E. Brightman may publish in the future.
Co-authors
The 25 scholars most cited alongside Spencer E. Brightman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 108 | |
| 2 | 2020 | 42 | |
| 3 | 2023 | 38 | |
| 4 | 1990 | 37 | |
| 5 | 2017 | 32 | |
| 6 | 2023 | 31 | |
| 7 | 2016 | 28 | |
| 8 | 2016 | 23 | |
| 9 | 2022 | 16 | |
| 10 | 2018 | 14 | |
| 11 | 2022 | 8 | |
| 12 | 2024 | 6 | |
| 13 | 2025 | 1 | |
| 14 | 2018 | 1 |
About Spencer E. Brightman
Spencer E. Brightman is a scholar working on Immunology, Oncology, Epidemiology, Microbiology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 385 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune Response and Inflammation (5 papers), Influenza Virus Research Studies (4 papers), Bacterial Infections and Vaccines (4 papers), Pneumonia and Respiratory Infections (3 papers) and Atherosclerosis and Cardiovascular Diseases (1 paper). The work is most often cited by research in Immunology (240 citations), Microbiology (36 citations), Oncology (94 citations), Immunology and Allergy (17 citations) and Infectious Diseases (51 citations). Spencer E. Brightman has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include Bruce R. Zetter, Stephen P. Schoenberger, Ofer Levy, David J. Dowling, Aaron M. Miller, Martin S. Naradikian, Carlo Pietrasanta, Ilana Bergelson, Simon D. van Haren and Bjoern Peters. Their work appears in journals such as Frontiers in Immunology, Current Opinion in Cell Biology, Science Translational Medicine, Scientific Reports and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.